General Information
Drug ID
DR00266
Drug Name
L-phenylalanine
Synonyms
(2S)-2-amino-3-phenylpropanoic acid; (L)-Phenylalanine; (S)-(-)-Phenylalanine; (S)-2-Amino-3-phenylpropanoic acid; (S)-2-Amino-3-phenylpropionic acid; (S)-Phenylalanine; (S)-alpha-Amino-benzenepropanoic acid; (S)-alpha-Amino-beta-phenylpropionic acid; (S)-alpha-Aminohydrocinnamic acid; 1F9436B3-8B0D-4AC6-A004-4249B0BDA436; 3-Phenyl-L-alanine; 3-Phenylalanine; 3-[4-[bis(2-chloroethyl)amino]phenyl]-2-formamidopropanoic acid; Alpha-Aminohydrocinnamic acid; Antibiotic FN 1636; Beta-Phenyl-L-alanine; Beta-Phenylalanine; CB 3208; Endophenyl; Fenilalanina; Fenilalanina [Spanish]; H-Phe-OH; L-3-(p-(Bis(2-chloroethyl)amino)phenyl)-N-formylalanine; L-Antibiotic FN 1636; L-PHENYL ALANINE (SEE ALSO 22839-47-0, ASPARTAME; L-PHENYLALININE; L-Phenylalanine (JP15); L-Phenylalanine, 4-(bis(2-chloroethyl)amino)-N-formyl-(9CI); N-Formyl-L-p-sarcolysin; N-Formyl-L-sarcolysin; N-Formylmelphalan; NCI9959; Phe; Phenylalanine; Phenylalanine (USP/INN); Phenylalanine (VAN); Phenylalanine [USAN:INN:JAN]; Phenylalaninum; Phenylalaninum [Latin]
Drug Type
Small molecular drug
Indication Dietary shortage [ICD11: 5B7Z] Approved [1]
Therapeutic Class
Dietary supplement
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=6140"></iframe>
3D MOL 2D MOL
Formula
C9H11NO2
Canonical SMILES
C1=CC=C(C=C1)CC(C(=O)O)N
InChI
InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1
InChIKey
COLNVLDHVKWLRT-QMMMGPOBSA-N
CAS Number
CAS 63-91-2
Pharmaceutical Properties Molecular Weight 165.192 Topological Polar Surface Area 63.3
Heavy Atom Count 12 Rotatable Bond Count 3
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 3
XLogP
-1.5
PubChem CID
6140
PubChem SID
10531434 , 11457628 , 11459655 , 11528323 , 11532528 , 14710668 , 15219430 , 24770335 , 24770338 , 24770342 , 24887247 , 24898274 , 24898657 , 24898971 , 24901797 , 26651814 , 26702643 , 26748791 , 26748792 , 26753740 , 29225143 , 3134198 , 3379 , 4252550 , 46391851 , 46393329 , 46505708 , 50107465 , 57323218 , 57578102 , 57652717 , 57654567 , 57655097 , 584667 , 6436530 , 78164833 , 7847089 , 7889851 , 81044023 , 81044025 , 81044569 , 81067307 , 81067312 , 8144203 , 8153851 , 822460 , 824902 , 832928 , 838754 , 841094
ChEBI ID
ChEBI:17295
TTD Drug ID
D0R1CR
DT(s) Transporting This Drug LAT2 Transporter Info L-type amino acid transporter 2 Substrate [2]
LAT3 Transporter Info L-type amino acid transporter 3 Substrate [3]
LAT4 Transporter Info L-type amino acid transporter 4 Substrate [4]
Drug-Transporter Activity Data
Drug-Transporter Activity Data LAT2 Transporter Info Km = 12.2 microM Xenopus oocytes-LAT2 [2]
References
1 L-phenylalanine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Quantifying the relative contributions of different solute carriers to aggregate substrate transport. Sci Rep. 2017 Jan 16;7:40628.
3 Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem. 2003 Oct 31;278(44):43838-45.
4 Anticipation of food intake induces phosphorylation switch to regulate basolateral amino acid transporter LAT4 (SLC43A2) function. J Physiol. 2019 Jan;597(2):521-542.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.